The comprehensive nonclinical testing program required to support clinical development and ultimate registration of a novel therapeutic involves years of work and many different types of studies. This nonclinical program - which begins prior to initiation of clinical trials and often continues after a drug is approved for marketing - is an essential component of the pharmaceutical R&D process and represents a considerable financial investment to the innovator.
Proficient design and support of nonclinical testing programs requires a customized and integrative strategy that is relevant to the intended clinical indication and acceptable to global health authorities.
Paracelsus can help your organization successfully meet this challenge by offering a range of professional consulting services. Discipline-specific expertise in key areas such as toxicology, veterinary pathology, pharmacology, pharmacokinetics is available to Paracelsus clients through highly knowledgeable and experienced professionals.